Ivabradina Fantex (Ivabradine Hydrochloride)

Ivabradine works by selectively blocking the funny (If) current in the sinoatrial node, the heart’s natural pacemaker. This inhibition slows spontaneous electrical activity, leading to a lower heart rate while leaving myocardial contractility, blood pressure, and ventricular repolarisation largely unaffected.

The exact dose of Ivabradina Fantex is determined by the prescribing clinician based on the patient’s clinical status, heart‑rate targets, and tolerability. Physicians typically start with a low dose and adjust it according to therapeutic response and safety monitoring.

Safety data for ivabradine in pregnancy and lactation are limited. The product should be avoided unless the potential benefit to the mother clearly outweighs any possible risk to the fetus or infant. Women of child‑bearing potential should use effective contraception while on therapy.

To place an order, submit an enquiry on the Ivabradina Fantex product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Both ivabradine and beta‑blockers lower heart rate, but they act via different mechanisms. Beta‑blockers reduce heart rate by blocking adrenergic receptors and also lower blood pressure, whereas ivabradine selectively inhibits the If current without affecting contractility or blood pressure. Ivabradine may be added when beta‑blockers alone do not achieve target heart rates or are not tolerated.

Store Ivabradina Fantex at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Ivabradina Fantex is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing relative to meals to maintain consistent absorption.

The most serious adverse events include symptomatic severe bradycardia, atrial fibrillation or other arrhythmias, marked hypotension, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, rapid palpitations, severe dizziness, or signs of an allergic response.

Ivabradina Fantex is contraindicated in patients with severe hypotension (systolic BP <90 mmHg), acute decompensated heart failure, sick sinus syndrome, or those with a resting heart rate below 50 beats per minute. It should also be avoided in individuals taking strong CYP3A4 inhibitors without appropriate dose adjustment.